drugset / Trial / NCT01921985

Terlipressin Administration in Patients Undergoing Major Liver Resection

NCT01921985 ↗

Phase 2 Terminated 150 enrolled Insel Gruppe AG, University Hospital Bern
RandomizedParallel-groupDouble-blindTreatment

Summary

This study investigates if the administration of terlipressin reduces complications after major liver surgery.

Timeline

Start
2013-11
Primary completion
2018-03
Completion
2018-03

Outcome

Outcome not reported

Stopped: “Interim analysis revealed that no statistical difference will be identified after inclusion of the patient cohort as foreseen in the sample size calculation”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terlipressin Peptide 1 mg Intravenous

Indications